🔗 Visit the ClinicalTrials.gov page for NCT02383316
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. | Curr Opin Genet Dev | 2009 | 5.53 |
| 2 | Receptor-specific regulation of phosphatidylinositol 3'-kinase activation by the protein tyrosine phosphatase Shp2. | Mol Cell Biol | 2002 | 2.03 |
| 3 | Noonan syndrome and clinically related disorders. | Best Pract Res Clin Endocrinol Metab | 2011 | 1.82 |
| 4 | A critical role for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of ras and mitogen-activated protein kinases by epidermal growth factor. | J Biol Chem | 2000 | 1.56 |
| 5 | A novel role for Gab1 and SHP2 in epidermal growth factor-induced Ras activation. | J Biol Chem | 2004 | 1.44 |